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Abstract 
 
Alcohol addiction is a complex disease that alters 
molecular pathways within the brain and leads to the 
development of alcohol tolerance.  One of alcohol’s 
primary targets in the brain is BK potassium channels. 
BK channels are alternatively spliced and the splice 
variant expression is regulated by miR-9. Exposure to 
alcohol upregulates miR-9, an miRNA that modifies the 
cellular composition of BK channel isoforms and 
contributes to alcohol tolerance.  The molecular 
mechanisms by which miR-9 is upregulated upon 
alcohol exposure are currently unknown.  We 
hypothesize that miR-9 upregulation occurs at the 
transcriptional and/or post-transcriptional level and that 
inhibition of miR-9 will diminish the acute and long-term 
effects of alcoholism.  We will investigate whether 
alcohol upregulates miR-9 through interactions with the 
miR-9 promoter and attempt to identify alcohol sensitive 
regions of the miR-9 promoter.  Another mechanism by 
which alcohol may upregulate miR-9 is by directing 
post-transcriptional miRNA maturation through 
interactions with the enzymes Drosha or Dicer.  Lastly, 
we will inhibit miR-9 expression through RNAi to 
characterize its role in ethanol sensitivity.  Identification 
of the mechanism underlying miR-9 upregulation after 
exposure to alcohol will not only provide further insight 
into alcohol addiction, but may also contribute to the 
development of potential therapeutic treatments for 
alcoholism. 
 
Background 
 
Drug addictions are pervasive diseases within modern 
society that result in substance dependence and are 
characterized by habitual drug use despite serious negative 
consequences. The most commonly abused drugs include 
heroin, nicotine, cocaine, and alcohol. Drug abuse is a 
societal burden costing the United States half a trillion 
dollars annually and affecting 7.5% of the US population 
over the age of 12 (1). Addictions are particularly complex 
diseases due to the involvement of multiple factors including 
genetics, neurobiology, and interactions with the 
environment (2).  Excessive drug abuse is known to induce 
molecular changes within the brain that promote continued 
drug use and increase an individual’s susceptibility to 
relapse after drug use has ceased (2, 3).  Habitual drug use 
also leads to tolerance as a result of decreased sensitivity to 
the drug (2).  One of the primary challenges in 
understanding addiction is identifying the molecular changes 
that underlie the development of dependence and tolerance. 
Identifying the molecular mechanisms and cellular 
adaptations involved in addiction is essential to 
understanding these neuronal disorders and in developing 
possible treatments. 
In alcohol addiction, BK potassium channels are a 
principal target and may play a central role in alcohol 
tolerance (4-7). BK channels are large-conductance, calcium 
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and voltage-activated potassium channels (8, 9). These 
channels are widely expressed in the brain, and they 
influence the initiation and propagation of action potentials 
(10, 11).  BK channels are alternatively spliced, and the 
production of different splice variants contributes to the 
functional diversity of BK channels in the brain (8).  
Alternative splicing of BK channels may also contribute to 
neuronal plasticity, which is essential to the development of 
addiction (8).   
The specific effects of alcohol on BK channels are 
still not well understood, although recent studies have 
provided important insight into the role of BK channels in 
behavioral and neurobiological responses to alcohol.  
Deleting the gene encoding neuronal BK channels in C. 
elegans decreases alcohol sensitivity (4).  Also, BK channels 
develop tolerance to alcohol in two mammalian brain regions 
significant to alcohol abuse and addiction: the supraoptic 
nucleus (SON) and the striatum (7).  Exposure to alcohol 
rapidly alters the composition of BK channel splice variants 
within SON and striatal neurons (8), and different BK 
channel isoforms have different sensitivities to alcohol (8).  
These changes in BK channel mRNA expression are the 
result of post-transcriptional regulation by the microRNA 
(miRNA) miR-9, which is upregulated by alcohol (8).  
Upregulation of miR-9 may thus contribute to both the acute 
effects of alcohol and the long-term development of 
tolerance (8).  In addition to BK channels, miR-9 is predicted 
to have multiple other targets that are involved in the 
nervous system’s response to alcohol (8). These findings 
indicate that miRNA, and more specifically miR-9, may have 
a significant role in the development of alcohol addiction and 
tolerance. 
miRNA are small (approximately 19-25 
nucleotides long), noncoding RNAs that silence gene 
expression post-transcriptionally (12 - 15). Emerging 
evidence shows that miRNAs play a role in numerous 
biological processes, including development, proliferation, 
and apoptosis, and they have been implicated in the 
pathogenesis of various diseases including cancer (12 - 15).  
Most miRNA are expressed under the control of their own 
promoters and regulatory sequences, but some are 
clustered together on DNA and may be co-regulated (12 - 
15).  The biogenesis of miRNA is a multi-step process in 
which primary miRNA (pri-miRNA) are cleaved within the 
nucleus into precursor miRNA (pre-miRNA) by an enzyme 
complex including Drosha, an RNase III family nuclease (16 
- 19). This is followed by processing of pre-miRNAs in the 
cytoplasm by Dicer, another RNase III, which cleaves the 
double stranded pre-miRNA to form mature miRNA (15, 21).  
The mature miRNA can regulate gene expression of 
complementary mRNAs by binding to the miRNA recognition 
element (MRE) in the 3’-untranslated region (3’UTR) of 
target mRNAs (8, 16).   
Although the scientific community has gained 
significant knowledge regarding miRNA biogenesis and 
biological function, very little is known about miRNA 
regulation. Currently, miRNA regulation is known to occur at 
two levels. miRNA can be regulated transcriptionally through 
regulatory sequences present in promoters or transcription 
factors (22). For example, miR-1 is regulated by the 
transcription factors MyoD, Mef2, and SRF (23). The 
expression of miRNA can also be regulated post-
transcriptionally by affecting the activity of Drosha and Dicer 
in miRNA maturation (Lee Y., et al. 2002; Obernosterer G.,, 
et al. 2006). For instance, SMAD protein interaction with 
Drosha regulates miR-21 expression (24). Furthermore, 
  
Dicer has been implicated in regulating the expression of 
miR-138 (25).  
As stated previously, miR-9 is up-regulated by 
alcohol exposure (8); however, the mechanism by which this 
occurs is unknown.  Additionally, miR-9 is known to play a 
significant role in the brain’s response to alcohol and the 
development of tolerance (8), yet it is not known whether 
miR-9 is required for ethanol sensitivity.  Given the 
importance of miR-9 in neuroadaptation to alcohol and its 
potential role in the development of alcohol addiction, it 
would be extremely valuable to identify the mechanism 
underlying miR-9 regulation by alcohol and to determine 
whether miR-9 is required for alcohol sensitivity.  
Our interest lies in the role of miRNA in the 
development of alcohol addiction.  We propose to test the 
hypotheses that alcohol is capable of upregulating the 
expression of miR-9 at the transcriptional and/or post-
transcriptional level and that miR-9 is required for ethanol 
sensitivity. 
 
Relevance 
 
Broader Relevance: Drug abuse is an escalating economic, 
health, and social concern in the United States, and it 
frequently leads to drug addiction.  Drug addictions cost the 
U.S. over half a trillion dollars annually and alcoholism 
accounts for $185 billion of the total expense (21). Alcohol 
addiction has potent health risks ranging from mental 
diseases to physical disorders, and in extreme cases may 
cause death (26, 27).  Thus, there is a need to elucidate the 
molecular mechanisms associated with the development of 
alcohol addiction. The findings of this proposal will clarify the 
molecular basis underlying alcohol addiction, which may 
contribute to the development of potential therapeutic 
treatments. 
 
Intellectual Merit: This proposal first seeks to identify the 
molecular mechanisms that lead to alcohol addiction. An 
understanding of these pathways may enhance further 
research regarding other drug addictions. We also propose 
to investigate the newly discovered miRNAs. Current 
evidence links the miRNA miR-9 to alcohol sensitivity and to 
the development of alcohol tolerance. miRNAs are 
ubiquitously expressed in mammals as regulatory molecules 
and are linked to disease pathogenesis (28, 29). Hence, 
discovering the mechanism by which miRNAs are regulated 
will provide more insight into the functional role of miRNAs in 
mammals. With these findings, we hope to foster knowledge 
within the scientific community. 
 
Specific Aims 
The long-term goal of this study is to clarify and find possible 
treatments for the molecular basis of alcohol addiction. This 
study will investigate how miR-9 is upregulated upon 
exposure to ethanol and the effects of miR-9 inhibition on 
ethanol sensitivity.  The hypotheses are that miR-9 
upregulation by ethanol depends on a specific molecular 
mechanism that affects transcription and/or miRNA 
maturation and that inhibition of miR-9 will diminish the acute 
effects of alcohol exposure while concomitantly reducing 
alcohol tolerance. 
 
1.     To characterize the role of the miR-9 promoter in 
miR-9 upregulation due to ethanol exposure:  miR-9 will 
be inserted with the miR-9 promoter into the pcDNA6.3V5-
pL-DEST gateway vector, which will be transfected into a 
HEK293 cell line.  We will then observe the effects of ethanol 
exposure on the transcription. We will do the same 
procedure with miR-131, another miRNA, and luciferase, a 
protein encoding gene.  We will also determine if there are 
alcohol sensitive region(s) of the miR-9 promoter. 
 
2.     To characterize miR-9 upregulation by examining 
ethanol’s effects on post-transcriptional miRNA 
maturation:  We will assess whether alcohol exposure 
upregulates pri-miR-9, pre-miR-9, and/or mature miR-9 
expression in rat striatal and SON neurons.  We will then use 
in vitro and in vivo assays to determine if alcohol upregulates 
miR-9 through interactions with either Drosha or Dicer. 
 
3.     To characterize ethanol sensitivity through the 
inhibition of miR-9: We will inhibit miR-9 functionality in rat 
SON and striatal neurons through RNA interference to 
evaluate miR-9’s role in ethanol sensitivity. We will use in 
vivo assays to examine any physiological changes in the 
cells that are caused by alcohol. 
 
Research Design and Methods 
 
1. To characterize miR-9 upregulation in DNA 
transcription through interactions between ethanol 
and the miR-9 promoter: 
 
Rationale:  We suspect that alcohol behaves like steroid 
hormones and heat shock proteins, which regulate gene 
transcription through regulatory sequences (30, 31). 
Therefore, we believe that alcohol upregulates miR-9 by 
targeting the miR-9 promoter. We will examine the role of the 
miR-9 promoter in response to alcohol exposure using the 
pcDNA6.3V5-pL-DEST gateway vector, a vector  without a 
promoter that can be expressed in mammalian cells. This 
vector will be transfected into HEK293 cells, which lack 
endogenous miR-9 (8). We will also couple the miR-9 
promoter with miR-131 and luciferase in order to confirm that 
alcohol affects the promoter independent of the gene with 
which it is coupled. 
 
Design and Method:  
1. The Effects of Ethanol on the miR-9 Promoter 
and Gene Transcription:  In order to determine the effects of 
ethanol on the miR-9 promoter, we will observe the 
transcription of miR-9 after alcohol exposure. In addition to 
using the miR-9 gene, we will use the miR-131 gene since it 
encodes a miRNA that is exclusively expressed in the brain 
(8).  Secondly, we will use the protein encoding gene 
luciferase, a well-documented reporter gene, because its 
transcription is easily measured through bioluminescence 
(32).  Since the miR-131 and luciferase genes are not known 
to be affected by alcohol, they should not be upregulated 
upon alcohol exposure unless they are coupled with the 
miR-9 promoter.  
The miR-9 promoter will be inserted into the 
pcDNA6.3V5-pL-DEST gateway vector with the miR-9, miR-
131, or luciferase gene (33).  The vectors will then be 
transfected into HEK293 cells.  We will also transfect 
HEK293 cells with an empty vector to serve as a control.  
The cells will be bathed in an ethanol-free medium or a 
medium containing 5mM, 20mM, or 50mM ethanol for 24 
hours. Total miRNA transcription will be measured using 
reverse transcription followed by real-time PCR using 
methods previously described (34, 35).  Transcription of the 
luciferase gene will be measured with a luminometer (36). 
Lastly, transcription will be analyzed using Northern blot. 
Prediction: We expect that alcohol will upregulate 
gene transcription via the miR-9 promoter, irrespective of the 
gene with which the promoter is associated. Thus, we 
believe the results will show that gene transcription will 
increase as the concentration of ethanol increases. 31	  
  
2. Identification of the miR-9 Promoter Region 
Affected by Alcohol: The proximal promoter (hereafter 
referred to as the promoter) region is the location of 
transcription factor binding and transcriptional regulation 
(37). We will attempt to identify the specific region of the 
miR-9 promoter where ethanol binds and upregulates 
transcription. Little is known regarding the structure of the 
miR-9 promoter.  Therefore, to determine the region 
responsible for ethanol’s effects, we will splice the promoter 
into three equal sections – identified as sections 1, 2, and 3. 
Each piece, as well as the core promoter, will be individually 
inserted into the pcDNA6.3V5-pL-DEST gateway vector with 
the miR-9, miR-131, or luciferase gene. We will then 
combine sections 1 and 2, 1 and 3, and 2 and 3 with the 
core promoter and insert these combinations into the vector 
with each of the aforementioned genes (38). These vectors 
will then be transfected into HEK293 cells. We will also 
transfect HEK293 cells with an empty vector to serve as a 
control. The cells will be bathed in an ethanol-free medium 
or mediums containing 5mM, 20mM, or 50mM ethanol for 24 
hours (7, 8). We will measure the transcription levels of the 
three genes when combined with the different promoter 
recombinants using the analyses described in section one.  
Prediction: We anticipate that one of the promoter 
regions (1, 2, 3, or a combination) will increase gene 
transcription when exposed to ethanol. This will demonstrate 
that alcohol interacts with one specific region of the 
promoter, thus upregulating miR-9 transcription. If ethanol 
does not upregulate miR-9 through the promoter, it must be 
upregulated through an alternative mechanism such as post-
transcriptional regulation of miRNA maturation. 
 
2. To characterize miR-9 upregulation by examining 
whether ethanol regulates post-transcriptional 
miRNA maturation. 
 
Rationale:  Several miRNAs are regulated at the post-
transcriptional level through processes that modulate miRNA 
maturation and involve interactions with enzymes that 
participate in miRNA biogenesis, such as Drosha and Dicer 
(3, 16, 25).  Therefore, we believe upregulation of miR-9 
after alcohol exposure may be occurring post-
transcriptionally through interactions with Drosha or Dicer.  
Rat striatal and SON neurons will be used to test expression 
of pri-miR-9, pre-miR-9, and mature miR-9 since miR-9 is 
known to be expressed in these cells (8).  In vitro and in vivo 
assays will then be used to evaluate interactions of miR-9 
with Dicer and Drosha since these are well-described 
methods for assessing enzyme activity in miRNA 
processing. 
 
Design and Method: 
1.  Ethanol’s Effect on miR-9 Biosynthesis: In 
order to investigate the effects of ethanol on miR-9 
biosynthesis, we will compare the relative abundance of pri-
miR-9, pre-miR-9, and mature miR-9 in untreated and 
ethanol-treated rat striatal and SON neurons.  The cells will 
be cultured in either ethanol-free medium (control group) or 
medium containing 20mM ethanol for 24 hours.  Total RNA 
will be extracted from cells by Trizol (Invitrogen) (24).  
Quantitative reverse transcription polymerase chain reaction 
(qRT-PCR) will then be carried out using primers designed 
for rat pri-miR-9, pre-miR-9, and mature miR-9 (24).  The 
products will be run on an agarose gel and analyzed using a 
densitometer (8).  Data analysis will be performed using 
software by BioRad (24). In the ethanol-treated cells, the 
expression level of miR-9 will be measured prior to exposure 
to ethanol and after exposure for 15 min, 30 min, 6 hrs, and 
24 hrs.  Expression level within control cells will be 
measured at the same time intervals.   
Prediction: If ethanol upregulates miR-9 through 
interactions with Drosha, then it will accelerate the 
conversion of pri-miR-9 to pre-miR-9, which will result in the 
expression of more pre-miR-9 and mature miR-9 in cells 
exposed to ethanol.  If, on the other hand, ethanol 
upregulates miR-9 through interactions with Dicer, then it will 
accelerate the conversion of pre-miR-9 to mature miR-9, 
resulting in the expression of more mature miR-9 after 
exposure to ethanol.   
 
2.  Ethanol’s Effect on Drosha Activity:  Ethanol’s 
effects on Drosha activity will first be evaluated using an in 
vitro pri-miRNA processing assay (24).  Radiolabeled pri-
miR-9 will be prepared by in vitro transcription and will then 
be incubated with nuclear extracts prepared from rat striatal 
and SON neurons that have been untreated (control) or 
treated with 20mM ethanol. The reaction mixtures will be 
subjected to denaturing gel electrophoresis and the amount 
of pri-miR-9 and pre-miR-9 will be quantified using a 
phosphoimager (24).  To demonstrate that ethanol is 
interacting with Drosha and is independent of the substrate, 
a second miRNA, miR-131, will be subjected to the same 
procedure; miR-131 is expected to behave like miR-9. We 
will perform a second in vitro assay to verify that ethanol is 
acting directly on the Drosha enzyme.  The assay will be 
executed as previously described (39, 40) and will use 
immuno-purified Drosha that will be incubated with miRNA 
(either miR-9 or miR-131) in the presence or absence of 
20mM ethanol.  The products will then be subjected to qRT-
PCR (as described in part 1), run on a gel, and measured 
using a densitometer.   
Next, Drosha-miR-9 interactions will be evaluated 
in vivo using RNA immunopreciptiation performed as 
previously described (41, 42).  Rat striatal and SON neurons 
will be bathed in either an ethanol-free medium (control) or a 
medium containing 20mM ethanol.  The cells will be lysed 
and incubated with anti-Drosha antibodies. They will then be 
exposed to Protein A-agarose beads, and miR-9 will be 
separated by qRT-PCR and analyzed as described in part 1. 
Prediction:  If ethanol upregulates Drosha activity, 
then more pri-miRNA should be converted to pre-miRNA in 
the ethanol-treated in vitro assays than in the untreated 
assays.  Additionally, the in vivo immunoprecipitation should 
show that there is more Drosha bound to pri-miRNA in 
ethanol-treated neurons than in untreated neurons.  If the 
results indicate that ethanol does not upregulate Drosha 
activity, then this would suggest that upregulation is 
occurring through a different mechanism such as through 
interactions with Dicer or the miR-9 promoter. 
 
3.  Ethanol’s Effect on Dicer Activity:  Ethanol’s 
effects on Dicer activity will be evaluated using the same 
procedures described in part 2.  The only modifications will 
be that in the first in vitro assay, cytoplasmic extract will be 
incubated with the pri-miR-9 instead of nuclear extract since 
Dicer activity occurs in the cytoplasm rather than in the 
nucleus (16).  Also, we will use immuno-purified Dicer in the 
second in vitro assay and anti-Dicer antibodies in the in vivo 
immunoprecipitation.   
Prediction:  If ethanol upregulates Dicer activity, 
then more pre-miRNA should be converted to mature miRNA 
in the ethanol-treated in vitro assays than in the untreated 
assays.  The in vivo immunoprecipitation should also show 
more Dicer bound to pre-miRNA in ethanol-treated neurons 
than in untreated neurons.  If the results indicate that ethanol 
does not upregulate Dicer activity, then upregulation must be 
occurring through an alternative mechanism such as through 
interactions with Drosha or the miR-9 promoter. 
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3. To characterize the effects of miR-inhibition. 
 
Rationale:  miR-9 alters the composition of BK channel 
isoforms in neurons and is linked to alcohol sensitivity and 
the development of tolerance (8).  Therefore, the next logical 
step would be to observe the effects of miR-9 inhibition in 
vivo. To examine the functional role of miR-9, we will inhibit 
this short non-coding RNA through RNA interference (RNAi). 
We will use two methods of RNAi: the first uses 2’-OMethyl 
(OMe) modified short interfering RNAs (siRNA) (42, 43) and 
the second utilizes locked nucleic acid (LNA). siRNA and 
LNA are commonly used inhibitors of miRNA (42, 43), but 
LNA proves more effective in miRNA inhibition than siRNA 
because it can bypass the plasma membrane and is more 
stable in vivo (44). We will use rat SON and striatal neurons, 
which naturally express miR-9, to study the effects of miR-9 
silencing on ethanol sensitivity by employing siRNA and LNA 
(7). 
 
Design and Method: 
1.  Antisense siRNA (Antigomir) activity:   We 
propose to study the effects of miR-9 inhibition using 
synthetic antisense siRNA (45). To prepare our antisense 
OMe siRNA, we must first obtain the reverse complement 
sequence of miR-9, which is available from 
http://microrna.sanger.ac.uk/sequences/ (45).  Once an 
oligonucleotide template has been made, commercially 
available 2’O-Me-Nucletoides can be purchased from 
Dharmacon (43, 45-46). The oligonucleotides will be purified 
by high-performance liquid chromatography (HPLC) and 
then used to synthesize siRNA by standard solid phase 
oligonucleotide synthesis protocols (47). The production of 
the siRNA will be verified using PCR (48, 49). Transfection 
of the siRNA into the SON and striatal neurons will require 
the siRNA to be placed into a plasmid and then into 5 µL of 
Lipofetamine 2000 (Invitrogen) for 4hrs.  These cells will 
then be removed and exposed to 20 mM ethanol to observe 
the effects of inhibited miR-9. Control cells will be placed in 
an ethanol-free medium. Furthermore, we will use anti-miR-
131 siRNA as our siRNA control molecule. This siRNA 
should not inhibit miR-9 function since it does not have a 
binding sequence complementary to miR-9. To observe the 
effects of miR-9 inhibition, both loss-of-function and control 
cells will be analyzed 15 min, 30 min, 6 hrs, and 24 hrs after 
ethanol exposure. To measure the physiological changes of 
the cell, we will perform three analyses. The first will be 
whole-cell patch clamp method to measure the differences in 
potassium current changes between control and ethanol 
exposed cells (4, 8). Secondly, the use of siRNA causes the 
degradation of the target miRNA (48, 49); thus, we will 
measure miR-9 levels in cells using Northern blot. Lastly, 
miR-9 changes the BK channel isoform composition (8).  We 
will then employ Western blots to evaluate the BK channel 
isoforms.   
Prediction: Inhibition of miR-9 with siRNA will 
reduce alcohol tolerance in these cells and prevent changes 
in BK channel isoform composition. However, it is possible 
that the cells will maintain alcohol tolerance after miR-9 
inhibition because alcohol may have other targets in the cell 
that regulate ethanol sensitivity.  Furthermore, miR-9 
inhibition may prove fatal to the cell as it has multiple targets 
within neurons (8). 
 
2.  Antisense LNA activity: We will also study LNA 
inhibition of miR-9. LNA has more therapeutic potential than 
siRNA because siRNA require plasmids and vectors to 
bypass the cell membrane. These transport vehicles may be 
toxic to cells and therefore could not be used therapeutically. 
Anti-miR-9 LNA oligionucleotides can be purchased from 
Biosynthesis (50). Transfection of the LNA into SON and 
striatal neurons will be achieved with a 40% confluent 
Lipofection (GIBCO/BRL) medium for 15 minutes (50).  The 
same experimental conditions, controls, and analyses will be 
used as in part 1. However, our control will be anti-miR-131 
LNA, which should not bind to miR-9 as it does not have a 
complementary sequence.   
Prediction: Inhibition of miR-9 with antisense LNA 
will reduce alcohol tolerance in these cells and prevent 
changes in BK channel isoform composition. However, 
alcohol tolerance may remain because ethanol may have 
multiple targets that influence ethanol sensitivity. 
Alternatively, it is possible that miR-9 inhibition may prove 
toxic, as miR-9 has multiple targets within neurons. 
 
Note: Eukaryon is published by students at Lake Forest 
College, who are solely responsible for its content. The 
views expressed in Eukaryon do not necessarily reflect 
those of the College. Articles published within Eukaryon 
should not be cited in bibliographies. Material contained 
herein should be treated as personal communication and 
should be cited as such only with the consent of the author. 
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